Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Thumbnail

Novartis launches FDA-approved study involving hydroxychloroquine, azithromycin, COVID-19 patients

Novartis is launching a new clinical trial to assess the effectiveness of treating hospitalized COVID-19 patients with hydroxychloroquine.

Thumbnail

E-cigarette use causes as much vascular damage as smoking cigarettes

E-cigarettes can cause just as much damage to a person’s arteries and blood vessels as traditional cigarettes, according to a new study published in the Journal of the American Heart Association.

Thumbnail

New Data Underscore Importance of Looking for HCM Before Scheduling TAVR

Reported in 2018 by anesthesiologists at the University of Florida College of Medicine in Gainesville, the case suggested a message to TAVR operators: “Vigilance and a high degree of suspicion” are critical for avoiding the potentially severe hemodynamic consequences of HCM associated with aortic stenosis, the authors asserted (J Med Case Rep 2018;18;12[1]:372).

Thumbnail

New CDC data finds hypertension on the rise—but it’s not what you think

There’s a reason to feel quite optimistic about these numbers—the rise comes from an updated definition of hypertension, one first suggested by the American College of Cardiology and American Heart Association.

Thumbnail

What high COVID-19 mortality among black patients tells us about CVD care in the US

The high mortality rates from COVID-19 among black patients and other racial/ethnic minorities put a much-needed spotlight on the “deep-rooted failures” of the U.S. healthcare system to improve care for cardiovascular disease (CVD), according to a new commentary.

Thumbnail

First COVID-19 death in US caused by a ruptured heart

The first known death from COVID-19 in the United States was caused by a ventricular rupture.  

Thumbnail

Evolocumab associated with significant drop in heart attack risk

Taking evolocumab to lower LDL cholesterol can lead to significant reductions in a patient’s risk of myocardial infarction (MI), according to new findings published by JAMA Cardiology.

Thumbnail

Quest Diagnostics invites healthcare consumers to request their own COVID antibody tests

The company announced the service launch April 28, saying individuals who want the test can request it online—cost: $119—without referral from a doctor.